Unmet needs for healthcare and social support services in patients with Huntington's disease: a cross-sectional population-based study by Van Walsem, Marleen Regina et al.
RESEARCH Open Access
Unmet needs for healthcare and social
support services in patients with
Huntington’s disease: a cross-sectional
population-based study
Marleen R. van Walsem1,2*, Emilie I. Howe1,3, Kristin Iversen4, Jan C. Frich5,6 and Nada Andelic1,3
Abstract
Background: In order to plan and improve provision of comprehensive care in Huntington’s disease (HD), it is
critical to understand the gaps in healthcare and social support services provided to HD patients. Research has
described utilization of healthcare services in HD in Europe, however, studies systematically examining needs for
healthcare services and social support are lacking. This study aims to identify the level and type of met and unmet
needs for health and social care services among patients with HD, and explore associated clinical and
socio-demographic factors.
Methods: Eighty-six patients with a clinical diagnosis of HD living in the South-Eastern region of Norway were
recruited. Socio-demographic and clinical characteristics were collected. The Needs and Provision Complexity Scale
(NPCS) was used to assess the patients’ needs for healthcare and social services. Functional ability and disease stage
was assessed using the UHDRS Functional assessment scales. In order to investigate factors determining the level of
total unmet needs and the level of unmet needs for Health and personal care and Social care and support services,
multivariate logistic regression models were used.
Results: A high level of unmet needs for health and personal care and social support services were found across all
five disease stages, but most marked in disease stage III. The middle phase (disease stage III) and advanced phase
(disease stages IV and V) of HD increased odds of having a high level of total unmet needs by 3.5 times and 1.4
times respectively, compared with the early phase (disease stages I and II). Similar results were found for level of
unmet needs in the domain Health and personal care. Higher education tended to decrease odds of high level of
unmet needs in this domain (OR = 0.48) and increase odds of higher level of unmet needs in the domain of Social
care and support (OR = 1.3). Patients reporting needs on their own tended to decrease odds of having unmet
needs in Health and personal care (OR = 0.57).
Conclusions: Needs for healthcare and social services in patients with HD should be assessed in a systematic
manner, in order to provide adequate comprehensive care during the course of disease.
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Background
Many rare diseases, such as Huntington’s disease (HD),
are chronic and complex, and are associated with phys-
ical, mental or neurological disabilities. Systematic as-
sessment of patients’ needs for healthcare and social
services may identify gaps that could lead to improved
service provision [1, 2].
HD is an autosomal dominant neurological disease
caused by an expanded CAG repeat in the Huntingtin
gene. The disease is characterized by progressive func-
tional decline and motor, psychiatric and cognitive symp-
toms, in addition to weight loss, sleep disturbances and
dysregulation of the autonomic nervous system [3–6]. A
clinical diagnosis of HD is given when unequivocal motor
symptoms are present, but subtle motor signs, psychiatric
symptoms and cognitive changes may be present years
prior to clinical diagnosis [7–11]. Clinical symptoms of
HD usually develop during adult life between 30 and
50 years of age and disease duration from first clinical
symptoms to complete care dependency and death is ap-
proximately 15–20 years [4].
At present, there is no curative treatment for HD, and
treatment is aimed at alleviating symptoms, maintaining
and improving function and quality of life [12]. HD pa-
tients in early to middle stages of the disease need coor-
dinated multidisciplinary healthcare services, including
assessment of cognitive function and counselling by
(neuro)psychologists [4], rehabilitation programs [13, 14],
active physiotherapeutic interventions [15, 16], speech
therapist training [4, 17, 18] and occupational therapy [4].
Patients in advanced stages of the disease are usually
dependent on full-time personal care, but may still benefit
from multidisciplinary care [19]. Family members experi-
ence challenges and need support and guidance [20].
Although there is general agreement that comprehen-
sive, multidisciplinary care is needed [4, 19, 21–24], the
complex and changing clinical picture may be a challenge
for health professionals. Standards of care, aimed at separ-
ate groups of healthcare professionals (i.e., speech and lan-
guage therapists) have been published, with the purpose of
being a foundation for further research and evaluation of
provided care [18, 25, 26]. A few clinics adapting compre-
hensive care models have emerged in the US, Australia
and Europe [4, 24, 27].
In order to plan and improve provision of long-term
care in HD, it is essential to understand what healthcare
and social services HD patients receive, and what unmet
healthcare needs they may have. A few studies have
assessed health and social care utilization and needs in
HD and results showed a number of unmet needs related
to body functions, activities and level of participation as
well as carer support [28, 29].
To date, research has not addressed healthcare needs
of HD patients in Norway. Norway, like the other
Scandinavian countries, is a welfare state with equal ac-
cess to health and social care services, and services are
either free or subsidized at point of delivery. Thus, the
Scandinavian studies on HD patients and delivery of
healthcare services may be of international interest.
The aims of the present study are threefold: a) to investi-
gate the level of unmet needs for healthcare and social
support services among HD patients, b) to investigate how
the level of unmet needs are divided across disease phases,
and c) to investigate the association between socio-
demographic and clinical disease characteristics and levels
of unmet needs.
We anticipated considerable levels of unmet needs for
healthcare and social support services across all phases
of the disease. Furthermore, we anticipated the advanced
disease phase to be highly associated with the level of
unmet needs for healthcare and social support services.
Methods
Participants and participant recruitment
Patients with a clinical diagnosis of HD residing in the
South-Eastern region of Norway, a region with a popu-
lation of 2.7 million, were invited to participate in a
survey of healthcare needs and utilisation of healthcare
services. Eligible patients were identified through the
Department of Neurology, Department of Neurohabil-
itation, and Department of Medical Genetics at Oslo
University Hospital, the regional academic medical cen-
ter. In addition, patients were recruited through the
Centre for Rare Disorders at Oslo University Hospital,
a national advisory service for HD that offers guidance
to patients, families and healthcare professionals. In a
further effort to reach all eligible patients, we collaborated
with a Norwegian professional network for community
care in HD (Huntington fagnettverk) and the Norwegian
HD lay association (Landsforeningen for Huntingtons syk-
dom). The Vikersund Rehabilitation Centre, which runs a
rehabilitation program for HD patients, were informed
about the study and issued invitations to additional
patients.
All eligible patients received a written invitation, en-
closing information about the study and an informed
consent form. Following return of the consent form, the
patient/carer was contacted and an appointment for a
study visit was made.
We identified a total of 158 eligible patients (which
correspond to a prevalence of 5.9/100.000) who were
invited to participate in the study, of which 88 patients
gave their consent to participate and were included.
Among the 70 patients who were not included, 27 de-
clined to participate and 43 did not reply (see Fig. 1 for
flow chart illustrating patient recruitment). An expert
HD clinician reviewed medical records if there was any
doubt about the diagnosis. Two patients did not have
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sufficient symptoms to formally have been given a clin-
ical diagnosis of HD and were therefore excluded. Fi-
nally, 86 (54.4 %) out of the 158 potential participants
were included in the data-analysis.
Ethics
The study was approved by the Regional Ethical Com-
mittee (ref. 2013/2089). Informed consent was obtained
for all patients. For patients who were unable to give in-
formed consent themselves, consent was obtained from
the primary caregiver or legal representative.
Data collection
Data were collected through interviews conducted by two
experienced clinical raters, either during an outpatient
study visit (38.0 %) or at the patients’ home (62.0 %). We
recorded with whom the interview was performed, i.e.,
patient alone, patient with primary informal and/or formal
carer, or informant only. Socio-demographic information
and clinical functional assessment was recorded at the be-
ginning of the visit. Co-morbid conditions not related to
HD were also recorded. Furthermore, patients were rated
regarding functional ability and needs for healthcare and
social services. Patients’ medical records were reviewed if
further information was needed.
Description of measurements
Unified Huntington’s disease rating scale – functional
assessment
The UHDRS-Functional assessment comprises three
scales: a) the Total Functional Capacity Scale (UHDRS-
TFC), rating ability to engage in occupation, manage
finances and domestic chores, and perform activities of
daily living (ADL), with a score range of 0 – 13. The
scale is used to classify patients into five functional dis-
ease stages, using the following convention: A TFC
score of 11–13 represents Stage I, a TFC score of 7–10
represents Stage II, TFC score of 3–6 represents Stage
III, a TFC score of 1–2 represents Stage IV and a TFC
score of 0 represents Stage V. b) the Functional Assess-
ment Scale (FAS), a daily living checklist with scoring
range 0–25, and c) the Independence scale (IS) with range
10 to 100. Higher scores indicate better functioning [30].
The Needs and Provision Complexity Scale (NPCS)
The NPCS was specifically developed to identify health-
care and social support needs among patients with long
term neurological conditions in the UK [2]. It is a brief
and practical tool for measuring the needs for healthcare
and social support of an individual, and the extent to
which those needs are met through service provision. At
the individual level, the NPCS can be used to monitor the
changing needs of patients over time and services pro-
vided to support them along the care pathway, while at a
population level it can identify gaps of service provision.
The NPCS clinician version consists of a 15-item measure
with six sub-scales and a total scoring range of 0–50 cov-
ering “low” to “high” levels of needs. It has two parts: a)
Part A (NPCS-Needs) which is completed by the clinician
to evaluate each patients’ need for health and social care,
b) Part B (NPCS-Gets) is a mirror image of the same in-
strument to evaluate the services that have been provided.
Furthermore, the NPCS consists of two main domains a)
Health and Personal care needs (score range 0–25), in-
cluding the following subscales: Healthcare (score 0–6),
Personal care score (0–10), Rehabilitation (0–9), and b)
Social care and support needs (score range 0–25), includ-
ing subscales Social and family support (score 0–13),
Equipment (score 0–3) and Environment (score 0–9). For
an overwiew of the NPCS, see Additional file 1.
The NPCS was translated by native speakers from
English to Norwegian and then back-translated to English
to check for accuracy. The translation was reviewed by ex-
pert researchers and clinicians in the field of healthcare
services and HD.
Fig. 1 Flow chart illustrating patient recruitment process
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Statistical analyses
Outliers and missing values
Prior to analysis, the data were screened for extreme
values and missing data. Some outliers were identified in
the data on sample characteristics and NPCS scores, and
checked with the original data material. These were true
values and therefore kept in the statistical analyses. Ini-
tially, four missing values for variables years of educa-
tion, level of education (lower vs. higher), and three for
occupation type (manual vs. non-manual) were identified
and later estimated from the patients’ medical records.
For four patients, we were unable to collect information
about disease duration (number of years with clinical
diagnosis of HD) during the survey interview, and we
used clinical information that was available through
medical records to estimate disease duration. For three
patients we were unable to attain CAG repeat number.
Additionally, information on one item in the NPCS scale
was missing (<2 %) for one participant.
Descriptive analyses
Descriptive statistics were used (proportions, mean
values, standard deviations (SD) or median values with
interquartile range, (IQR)) in order to describe the
socio-demographic and clinical disease characteristics
of the complete sample and across the five disease
stages. Cross tabulations’ Chi-square tests were used in
order to compare nominal socio-demographic and clin-
ical characteristics across disease stages. Group com-
parisons across disease stages for continuous variables,
were calculated using Non-parametric Kruskal-Wallis
k-sample tests, as the data were not normally distrib-
uted (with exception of participants age).
Descriptive analyses for NPCS needs, gets and unmet needs
Scores for levels of unmet needs (representing gaps be-
tween patients’ needs for healthcare and social support
services and provision of these services) were calculated
as the discrepancy between the scores for level of the pa-
tients’ Needs and Gets (Score on NPCS Needs – Score
on NPCS Gets = NPCS Unmet needs). The level of un-
met needs were calculated for the NPCS Total score, for
the domain scores Health and personal care and Social
care and support, as well as for the six corresponding
subscales. Descriptive statistics presented by median
values with interquartile scores were used in order to
present the level of patients’ needs, the level of provision
(Gets), and the level of unmet needs for the total sample
as well as for disease stage I-V. Additionally, frequencies
and proportions of patients with unmet needs on each of
the NPCS scores were calculated for the total sample
and five disease stages. Group comparisons across the five
disease stages for levels of needs, gets and unmet needs
and for frequencies were made using Kruskal-Wallis k
sample test. The p-value was set at 0.05.
Evaluating effects on the level of unmet needs
In order to investigate the factors determining the level
of total unmet needs, and the level of unmet needs for
Health and personal care and Social care and support
services, multivariate logistic regression models were
used. Regression analyses were performed on the group
of patients having unmet needs on the NPCS total score
and the two main domains health and personal care and
social care and support. The NPCS total score and the
domain scores were categorized into two groups based
on median value: low level of unmet needs vs. high level
of unmet needs. This resulted in the following categor-
ies: NPCS Total unmet needs: low level (1–6) vs. high
level of unmet needs: >6); NPCS Health and personal
care unmet needs: Low level (1–3) vs. high level (>3);
NPCS social care and support unmet needs: Low level
(1 & 2) vs. high level (>2). Due to the small number of
patients, the five disease stages were collapsed into
three disease phases: early phase (disease Stage I & II),
middle phase (Stage III) and advanced phase (Stages IV
& V) in the regression analyses. Statistically significant
factors (level of education (lower vs. higher), informant
(patient alone vs. patient and informant/informant alone)
and disease phase (early, middle or advanced) from the
univariate analyses including simple logistic regression
were included in the multivariate models in order to in-
vestigate their impact on the total level of unmet needs
and unmet needs for health and personal care and social
care and support. We applied similar multivariate models
to demonstrate that certain factors are common and con-
sistently important. To control for the heterogeneity in
the included sample, all models were adjusted for age
(years), disease duration (years), and comorbidity (yes/no).
Results from the multiple logistic regression analyses are
presented with odds ratios (OR) with 95 % confidence in-
tervals. Furthermore, the Hosmer-Lemeshow goodness-
of-fit statistics were computed. Prior to conducting the lo-
gistic regressions we investigated multicollinearity. The
variables with correlation coefficients > .70 were not en-
tered in the regression analyses. All analyses were con-
ducted using SPSS version 21.0; SPSS Inc. Chicago IL.
Results
Socio-demographic and clinical description of the
patients
The socio-demographic characteristics for the total sample
and across disease stages are summarized in Table 1. The
median age was 57.5 years, and 54.7 % of the patients were
men. The majority of patients lived at home (62.8 %). Of
the complete sample of 86 patients, 12 (14 %) were in
stage I, 23 (26 %) in stage II, 19 (22 %) in stage III, 15
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(18 %) in stage IV, and 17 (20 %) in stage V. Overall, sig-
nificant group differences across disease stages were found
for variables Occupational situation, Housing situation
and Informant.
Clinical characteristics for the total sample of patients
across disease stages are presented in Table 2. The me-
dian values for disease duration, total FAS score and
FAS independence scores were respectively 6.1 (IQR 6.8)
years, 15 (IQR 17), 70 (IQR 35). Of the complete sample,
36 (42 %) patients had comorbid conditions, 5 (42 %) in
disease stage I, 13 (56 %) in disease stage II, 10 (53 %) in
disease stage III, 4 (27 %) in disease stage IV, and 4
(23 %) in disease stage V.
Description of healthcare and social support needs,
provision and unmet needs
Bargraphs with median values for disease stages I-V for
the NPCS total, domain and subscale scores for Needs,
Gets and Unmet needs are presented Fig. 2. In general, the
median values for NPCS total score and domain scores for
Needs and Gets increase from disease stage I – IV, and
remain stable from stage IV to V. NPCS Needs and Gets
median values for subscales Personal care and Accommo-
dation follow a similar pattern.
Proportions of patients with unmet needs in the total
sample and across disease stages are presented in Table 3.
Results show high proportions of patients with unmet
needs for NPCS total score (92 %), domains Health and
personal care (83 %), and Social care and support (79 %),
and subscales Rehabilitation (74 %) and Social and fam-
ily support (66 %). The highest proportion of patients
with unmet needs for the overall and domain scores was
found in disease stage III (95 % each). Comparing the
proportions of patients with unmet needs between
stages, significant group differences were found on
subscales Personal Care (p = 0.00) and Accommodation
(p = 0.00).
Factors associated with level of unmet needs across the
disease phases (early, middle and advanced)
The results of modelling total level of unmet needs
(NPCS total score unmet needs) and level of unmet
Table 1 Socio-demographic statistics for complete sample and divided across V disease stages
Complete sample
(N = 86)
Stage I
(n = 12)
Stage II
(n = 23)
Stage III
(n = 19)
Stage IV
(n = 15)
Stage V
(n = 17)
Variables Categories Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median (IQR) Sign
Agea 58 (15) 49 (20) 54 (21) 58 (11) 58 (8) 59 (16) 0.104
Education
(years/)b
12 (5) 13 (5) 12 (7) 11 (2) 12 (6) 11 (6) 0.168
n (%) n (%) n (%) n (%) n (%) n (%) P-value
(2sided)
Gender Female 39 (45) 5 (42) 9 (39) 7 (37) 8 (53) 10 (59) 0.625
Male 47 (55) 7 (58) 14 (61) 12 (63) 7 (47) 7 (41)
Education Lower 52 (60.5) 5 (42) 12 (52) 15 (79) 9 (60) 11 (65) 0.424
Higher 34 (39.5) 7 (58) 11 (48) 4 (21) 6 (40) 6 (35)
Sivil status Single 36 (42) 4 (33) 7 (30) 9 (47) 8 (53) 8 (47) 0.587
Married 50 (58) 8 (67) 16 (70) 10 (53) 7 (47) 9 (53)
Occupationc Manual 41 (48) 5 (42) 10 (43.5) 12 (63) 6 (40) 8 (47) 0.666
Non-manual 42 (49) 7 (58) 13 (56.5) 7 (37) 8 (53) 7 (41)
Occupational
status
Employed 14 (16) 11 (92) 3 (13) 0 (0) 0 (0) 0 (0) 0.001
Unemployed 72 (84) 1 (8) 20 (87) 19 (100) 15 (100) 17 (100)
Informant Patient 27 (31) 9 (75) 14 (61) 4 (21) 0 (0) 0 (0) 0.001
Patient & informant/
informant only
59 (69) 3 (25) 9 (39) 15 (79) 15 (100) 17 (100)
Housing situation Living at home 54 (63) 12 (100) 23 (100) 13 (68) 6 (40) 0 (0) 0.001
Not living at home 32 (37) 0 (0) 0 (0) 6 (32) 9 (60) 17 (100)
Residence Rural 13 (15) 1 (8) 4 (17) 2 (10.5) 3 (20) 3 (18) 0.878
Urban 73 (85) 11 (92) 19 (83) 17 (89.5) 12 (80) 14 (82)
IQR Interquartile range; Group comparison across the five disease stages performed using Chi-square tests for independent samples (categorical values). anormally
distributed and therefore reported result from ANOVA). bnot normally distributed therefore performed and reported Kruskal-Wallis test. c3 responses missing (1 in
stage IV and 2 in stage V). Remaining proportions and comparisons are crosstabs / Chi-square. IQR: Interquartile range
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needs for the two NPCS domains Health and personal
care and Social care and support respectively are dis-
played in Table 4. Being in the middle and advanced
phase of HD increased the odds of having a high level of
total unmet needs by 3.5 times (OR = 3.5) and 1.4 times
(OR =1.4) respectively, whereas the patient reporting
their needs without help from an informant tended to
decrease the odds of having high level of unmet needs
(OR =0.52). Similar results were found for level of unmet
needs in the domain Health and personal care: the middle
and advanced phase of HD tended to increase the odds of
having a high level of unmet needs (OR = 2.77 and OR
2.20 respectively). Additionally, higher education and pa-
tients reporting their needs without help from an inform-
ant tended to decrease the odds of reporting a high level
of unmet needs in this domain (OR = 0.48 and OR = 0.57
respectively). Furthermore, higher education tended to in-
crease the odds of reporting a high level of unmet needs
in the domain of Social care and support (OR = 1.3). Hav-
ing comorbid conditions tended to decrease the odds of
reporting a high level of unmet needs for Social care and
support (OR = 0.65). Results of residual analyses identi-
fied two extreme cases for the model for the Total level
of unmet needs. Removing the cases from the analyses
did not change the results. No outliers were identified
for the level of unmet needs on either of the NPCS do-
mains. Hosmer and Lemeshow tests for goodness-of-fit
were satisfactory for all three models.
Discussion
This is the first study to systematically investigate to
which extent healthcare and social needs are met in a
Table 2 Sample clinical characteristics
Complete sample
(N =86)
Stage I
(n = 12)
Stage II
(n = 23)
Stage III
(n = 19)
Stage IV
(n = 15)
Stage V
(n = 17)
Variables Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median (IQR) Sign
Disease duration 6 (7) 2 (2) 5 (6) 7 (5) 8 (7) 10 (8) P < 0.001
Total FAS score 15 (17) 24 (2) 20 (2) 15 (4) 5 (2) 0 (3) P < 0.001
Independence score 70 (35) 97 (9) 80 (5) 65 (10) 45 (20) 20 (6) P < 0.001
n (%) n (%) n (%) n (%) n (%) n (%) P-value
(2-sided)
Comorbid conditions 0.157
None 50 (58) 7 (8) 10 (12) 9 (10) 11 (13) 13 (15)
Neurological 1 (1.2) 1 (1.2) 0 (0) 0 (0) 0 (0) 0 (0)
Heart and vessels 8 (9.3) 2 (2.3) 2 (2.3) 2 (2.3) 2 (2.3) 0 (0)
Lung 2 (2.3) 0 (0) 0 (0) 2 (2.3) 0 (0) 0 (0)
Cancer 4 (4.8) 0 (0) 1 (1.2) 1 (1.2) 1 (1.2) 1 (1.2)
Muskulosceletal 5 (5.8) 0 (0) 3 (3.5) 2 (2.3) 0 (0) 0 (0)
Other 9 (10.5) 2 (2.3) 2 (2.3) 2 (2.3) 0 3 (3.5)
Multiple 7 (8.1) 0 (0) 5 (5.8) 1 (1.2) 1 (1.2) 0 (0)
FAS Functional Assessment Scale, IQR Interquartile range; Group comparisons are completed using Chi-square tests for categorical variables and Kruskall-Wallis for
continuous/interval variables, as none of the continuous variables were normally distributed
Fig. 2 Bargraphs illustrating level of needs, provision and unmet needs for NPCS total, domain and subscale scores
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representative sample of HD patients by using the newly
developed Needs and Provision Complexity Scale (NPCS).
As expected, the results indicate a high frequency of un-
met needs and gaps in provision of healthcare and social
support services at the overall level and in the domains
health and personal care and social support services across
all five disease stages. More than half of the patients had
unmet needs in the NPCS subscales, including Rehabilita-
tion and Social and family support. The results are, in gen-
eral, in agreement with a previously mentioned survey in
the UK [28], and a recent study of HD patients in Europe
[29], and thus, may represent the real needs of the HD
population.
Contrary to our hypothesis, the results suggest that
the most substantial gaps between healthcare and social
support service needs and provision are in the middle
phase (disease stage III) of HD, in terms of both pro-
portion of patients and level of unmet needs. Patients
in this phase represent a heterogenic group, due to
higher variation in symptom presentation and progres-
sion [31]. A prerequisite for offering adequate help in
the middle phase of HD is that healthcare providers
understand the needs of these patients and collaborate
with family caregivers [32]. Thus, a stronger focus on
monitoring patients’ symptoms and functioning is war-
ranted, and healthcare services need to be targeted to
this specific group of HD patients. Even though the level
of needs for social and healthcare services as a total are
greater in disease stages IV and V, these patients receive a
higher amount of services, resulting in a smaller amount
of unmet needs. This may be due to symptoms being
more overt in these stages causing patients to no longer
being able to carry out daily activities independently,
which may lead to greater awareness of the needs of these
patients. Indeed, observations from clinical practice indi-
cate that HD patients in later stages tend to have a higher
caregiver frequency and are more often cared for outside
the home. Our findings are also in line with research on
patient with long-term neurological conditions reporting
that patients whose rehabilitation needs were met were
more dependent at 12 months after discharge from hos-
pital than those with unmet needs [33]. Furthermore,
studies identifying unmet needs after traumatic brain in-
jury indicate that patients with more visible needs have a
higher degreee of met needs, which may reflect that health
professionals are working actively and responsibly for the
patient; thus, the patients are more satisfied and perceive
their needs as met [34].
Table 3 Proportions of unmet needs among participants
Complete sample
(N = 86)
Stage I
(n = 12)
Stage II
(n = 23)
Stage III
(n = 19)
Stage IV
(n = 15)
Stage V
(n = 17)
Variable n (%) n (%) n (%) n (%) n (%) n (%) P-value
(2 sided)
NPCSa total score Met needs 6 (7) 1 (8) 2 (9) 0 (0) 1 (7) 2 (12) 0.723*
Unmet needs 79 (92) 11 (92) 21 (91) 18 (95) 14 (93) 15 (88)
Domain score Health
and Personal care
Met needs 15 (17) 3 (25) 5 (22) 1 (5) 2 (13) 4 (23.5) 0.502*
Unmet needs 71 (83) 9 (75) 18 (78) 18 (95) 13 (87) 13 (76.5)
Subscale Healthcare Met needs 59 (69) 10 (83) 18 (78) 11 (58) 9 (60) 11 (65) 0.426*
Unmet needs 27 (31) 2 (17) 5 (22) 8 (42) 6 (40) 6 (35)
Personal Care Met needs 35 (52) 12 (100) 16 (70) 5 (26) 5 (33) 7 (41) 0.001
Unmet needs 41 (48) 0 (0) 7 (30) 14 (74) 10 (67) 10 (59)
Rehabilitation Met needs 22 (26) 4 (33) 6 (26) 1 (5) 6 (40) 5 (29) 0.180*
Unmet needs 64 (74) 8 (67) 17 (74) 18 (95) 9 (60) 12 (71)
Domaina score Social
Care and Support
Met needs 17 (20) 5 (42) 4 (17) 0 (0) 4 (27) 4 (23.5) 0.070*
Unmet needs 68 (79) 7 (58) 19 (83) 18 (95) 11 (73) 13 (76.5)
Subscale Social and family supporta Met needs 28 (33) 6 (50) 6 (26) 2 (10.5) 6 (40) 8 (47) 0.098*
Unmet needs 57 (66) 6 (50) 17 (74) 16 (84) 9 (60) 9 (63)
Specialist equipment Met needs 45 (52) 8 (67) 13 (56.5) 6 (32) 9 (60) 9 (53) 0.310
Unmet needs 41 (48) 4 (33) 10 (43.5) 13 (68) 6 (40) 8 (47)
Accommodation Met needs 59 (69) 12 (100) 20 (87) 12 (63) 8 (53) 7 (41) 0.002*
Unmet needs 27 (31) 0 (0) 3 (13) 7 (37) 7 (47) 10 (59)
NPCS Needs and Provision Complexity Scale; Chi-square test for categorical variables was used; *Five or less cells have expected count less than five. amissing data
(1 missing NPCS total score, disease stage III; 1 missing domain score social care and support, disease stage III; 1 missing subscale social and family support,
disease stage III)
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Factors associated with level of unmet needs across the
disease phases
Furthermore, we aimed to assess which socio-demographic
and clinical factors were associated with the level of unmet
needs for healthcare and social support services. Modelling
unmet needs further illustrated the association between
disease phase and level of unmet needs for the total level
of unmet needs and in the domain Health and personal
care. A lower level of education tended to decrease the
odds of having a high level of unmet needs in health and
personal care domain. One possible explanation for this
finding can be related to trends in the general population;
people with higher education are more resourceful and
have a better understanding and awareness of what health-
care and social support services are available or that they
are entitled to, as well as more resources to follow up on
receiving the services they need [35]. As a consequence
they may report a greater amount of unmet needs. Re-
gardless, we have to interpret this result with caution, as
we did not address patients cognitive or behavioral states
in this study.
Furthermore, if the survey interview was conducted with
the patient only, results showed trends toward decreased
odds of having high levels of unmet needs. This may re-
flect patients’ having reduced awareness of their symptoms
causing them to underreport and deny needs for health
and personal care services. On the other hand, research
has shown that in some cases, proxies tend to overesti-
mate patient disability [36] and hence, may overestimate
the patients’ needs for healthcare and social services. This
often appears to be the case in clinical practice and the
“truth” often seems to be somewhere in the middle.
None of the socio-demographic and clinical factors in-
cluded were significantly associated with level of unmet
needs in the social care and support domain. However,
education level tended towards an impact on this domain
as higher education increased the chance of having higher
levels of unmet needs. A contradiction seemed to emerge
with this result as a higher educational attainment, in gen-
eral, has been associated with higher levels of social sup-
port. Future studies are needed to tease this apart, as our
data are limited in their ability to provide more insight.
Furthermore, comorbidity tended to decrease the chance
of having higher levels of unmet needs for social care and
support in this study. The presence of comorbid condi-
tions has been associated with poorer social functioning
and further research is needed for a fuller understanding
of this finding.
Modelling the gaps in healthcare and social support
services provide additional support to the overall level of
Table 4 Factors associated with level of unmet needs using binary multiple logistic regression models for total level of unmet
needs (NPCS total score), level of unmet needs for health and personal care services (NPCS health and personal care score) and for
level of unmet needs for social care and support services (NPCS social care and support score)
NPCS unmet needs:
total (N = 79)
NPCS unmet needs: domain health and
personal care (N = 71)
NPCS unmet needs: domain social care
and support (N = 68)
Socio-demographic
and clinical Variables
Multivariate analysis
OR (95 % CI)**
Multivariate analysis OR (95 % CI)*** Multivariate analysis OR (95 % CI)****
Age 1.03 (0.98 – 1.08) 1.02 (0.97 – 1.07) 1.00 (0.96 – 1.05)
Education Level 0.78 (0.28 – 2.22) 0.48 (0.16 – 1.45) 1.40 (0.467 – 3.95)
High education vs. lower educationa
Disease duration 0.97 (0.86 – 1.10) 0.98 (0.86 – 1.13) 1.00 (0.89 – 1.13)
Comorbidity 0.91 (0.31 – 2.70) 0.83 (0.25 – 2.74) 0.65 (0.22 – 1.90)
Comorbidity vs. no comorbiditya
HD Phase 3.57 (0.89 – 14.4)***** 2.77 (0.62 – 12.36) 1.06 (0.27 – 4.18)
Middle phase vs. early phasea
HD Phase 1.38 (0.32 – 6.0) 2.20 (0.42 – 11.67) 1.06 (0.24 – 4.75)
Advanced phase vs. earlya
Informant 0.52 (0.13 – 2.04) 0.57 (0.14 – 2.30) 1.03 (0.24 – 3.6)
Patient vs. patient with informanta
aReference group
*OR > 1 increase the Odds of having a high level of unmet needs; OR < 1 decrease the odds of having high level of unmet needs
**Hosmer and Lemeshow Goodness-of-fit test χ2 9.12; df 8; P = 0.332
***Hosmer and Lemeshow Goodness-of-fit test χ2 6.63; df 8; P = 0.612
**** Hosmer and Lemeshow Goodness-of-fit test χ2 6.65; df 8; P = 0.575
*****Approached significance (p = 0.074)
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unmet needs and level of unmet needs for health and
personal care increasing considerably for patients in the
middle phase of HD. As mentioned before, the middle
phase of HD represents a largely heterogenic group of
patients, and this phase may present the most challenges
and unmet needs as the family starts to see an increase
of symptoms and the person with HD may have cogni-
tive deficits and struggle to see their own problems. It
can be considered a transitional phase, where patients
progress from being relatively independent to becoming
increasingly dependent in various areas of daily life. The
transitional character of this phase may cause additional
challenges in providing the tailored multidisciplinary
healthcare these patients need. Providing adequate care
to patients with HD should include regular monitoring
and evaluation of symptoms and functioning from the
moment of diagnosis, but may be particularly important
in the middle phase. One of the important messages to
clinicians is to not only evaluate clinically but also follow
up patients and assess needs for healthcare and social
services in a systematic manner, in order to provide ad-
equate comprehensive care during the course of disease.
Limitations and strengths
The present study has some methodological limitations.
Firstly, a cross-sectional study design prevents us from
discussing any causal relationship between independent
variables and NPCS scores representing levels of unmet
needs. The results need to be further studied with a lon-
gitudinal study design and, ideally, in a larger population
of HD patients.
Secondly, the response rate of 54.4 % cases reduced
power of our analyses, and some form of population bias
cannot be excluded. Patients with reduced self-awareness
may not be in contact with healthcare institutions and
therefore may have fallen out of reach. If they did receive
an invitation they may have declined or chose not to reply
because they do not perceive themselves as being ill. Add-
itionally, patients in late stages of the disease are highly
dependent on their primary (family) carers who may not
have had the time or energy to reply. Yet, considering the
clinical picture of HD, the population in this study may be
considered representative and our response rate can be
considered satisfactory. A strength in the present study is
that contrary to many studies (i.e., [29], patients in the
advanced phase (stages IV and V) were not underrepre-
sented. However, one of the most important limitations
is that behavioral and cognitive domains were not ad-
dressed in this study due to the fact that the data were
collected by a survey and not by clinical evaluation.
Thus, the interpretation of the study results should be
made with caution.
The NPCS was not validated for Norwegian language
and circumstances. Yet, the instrument has shown good
psychometric properties [37] and is originally developed
for this type of patient populations. There are currently
no other instruments available to assess needs for
healthcare and social support services in a similar nor-
mative and systematic manner. In order to ensure
obtaining best possible reliability of results obtained
using the NPCS Scale we discussed each of the NPCS
items regarding the interpretation for rating in the con-
text of the Norwegian healthcare system and this par-
ticular patient group, in addition to a carefully executed
translation process.
Implications and future directions
The results of the present study suggest that particular
focus should be warranted for patients entering the middle
phase of HD. Investigating factors associated with the level
of unmet needs for healthcare and social support services
further suggest that the patients’ education level may be of
importance when surveying the needs for healthcare ser-
vices in HD patients. Also, when discussing needs and
provision of services, an informant closely related to the
patient should ideally be present. Further studies including
a larger population and longitudinal study design should
be performed in order to verify the results of the present
study and to shed further light on the predictive factors
for level of unmet needs. Of particular interest are the
needs for social and family support [20]. Moreover, closer
investigating the potential influence of cognitive and psy-
chiatric symptoms and self-awareness on levels of unmet
needs for healthcare and social support services deserves
further research.
Conclusions
This study indicates unmet needs for health and personal
care and social support services among HD patients and
across all five disease stages. However, the most substan-
tial gaps in healthcare and social support services were
identified in the middle phase (disease stage III) of HD (in
terms of both proportion of patients and level of unmet
needs). One important message to clinicians is to not only
evaluate the patients clinically, but also follow up patients
and assess needs for healthcare and social services in a
systematic manner, in order to provide adequate compre-
hensive care during the course of disease.
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